On Thursday, May 11, the Senate Committee on Health, Education, Labor and Pensions marked up the proposed Food and Drug Administration (FDA) user fee reauthorization bill and voted 21-2 to advance it to the full Senate. The bill would reauthorize the
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/05/15/fda-user-fee-reauthorization-clears-hurdle-in-senate-with-bipartisan-support/
Posted
May 15 2017, 11:30 AM
by
Health Affairs BlogHealth Affairs Blog